Computational discovery of tissue morphology biomarkers in very long-term survivors with pancreatic ductal adenocarcinoma
Jacob S. Sarnecki, Laura DeLong WoodiD, Christopher Lee WolfgangiD, Ralph H. HrubaniD, Anirban MaitraiD, Denis WirtziD, Pei-Hsun WuiD
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest forms of cancer, with an average 5-year survival rate of only 8%. Within PDAC patients, however, there is a small subset of patients who survive >10 years. Deciphering underlying reasons behind prolonged survival could potentially provide new opportunities to treat PDAC; however, no genomic, transcriptomic, proteomic, or clinical signatures have been found to robustly separate this subset of patients. Digital pathology, in combination with machine learning, provides an opportunity to computationally search for tissue morphology patterns associated with disease outcomes. Here, we developed a computational framework to analyze whole-slide images (WSI) of PDAC patient tissue and identify tissue-morphology signatures for very long term surviving patients. Our results indicate that less tissue morphology heterogeneity is significantly linked to better patient survival and that the extra-tumoral space encodes prognostic information for survival. Based on information from morphological heterogeneity in the tumor and its adjacent area, we established a machine learning model with an AUC of 0.94. Our analysis workflow highlighted a quantitative visual-based tissue phenotype analysis that also allows direct interaction with pathology. This study demonstrates a pathway to accelerate the discovery of undetermined tissue morphology associated with pathogenesis states and prognosis and diagnosis of patients by utilizing new computational approaches.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A prospectively validated machine learning model for the prediction of survival and tumor subtype in pancreatic ductal adenocarcinoma
Georgios A. Kaissis, Sebastian Ziegelmayer, … Rickmer Braren·European Radiology ExperimentalPeer-reviewed·Oct 17, 2019
- Machine Learning-Based Identification of Survival-Associated CpG Biomarkers in Pancreatic Ductal Adenocarcinoma
Yu Zhang, Yining Zhao, Bo Zhang·The Journal of Precision Medicine Health and DiseasePeer-reviewed·Jun 27, 2026
- Meta-analysis of 1,200 transcriptomic profiles identifies a prognostic model for pancreatic ductal adenocarcinoma
Vandana Sandhu, Knut Jørgen Labori, … Benjamin Haibe‐Kains·JCO Clinical Cancer InformaticsPeer-reviewed·May 9, 2019
- Deeper insights into long-term survival heterogeneity of Pancreatic Ductal Adenocarcinoma (PDAC) patients using integrative individual- and group-level transcriptome network analyses
Archana Bhardwaj, Claire Josse, … Kristel Van Steen·Scientific ReportsPeer-reviewed·Jun 30, 2022
- DEVELOPMENT OF A CONSENSUS MOLECULAR CLASSIFIER FOR PANCREATIC DUCTAL ADENOCARCINOMA
Pablo Villoslada-Blanco, Lola Alonso, … Núria Malats·Genome MedicinePeer-reviewed·Nov 14, 2025
- PACpAInt: a deep learning approach to identify molecular subtypes of pancreatic adenocarcinoma on histology slides
C. Saillard, F. Delecourt, … J. Cros·bioRxiv·Jan 4, 2022